Table 1: Predetermined latency periods for calculations of population attributable risk for overweight/obesity, by cancer site and CCHS cycle of prevalence data used

Cancer site	Latency period, yr	Corresponding CCHS cycle (yr)
Esophagus	11-12	1.1 (2000-2001)
Pancreas	9	2.1 (2003)
Colorectum	9	2.1 (2003)
Kidney	11-12	1.1 (2000-2001)
Gall bladder	11-12	1.1 (2000-2001)
Breast	9	2.1 (2000-2001)
Endometrium	11-12	1.1 (2000-2001)
Note: CCHS = Canadian Community Health Survey.